These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9875373)

  • 1. Combinations of antiviral and anti-inflammatory preparations for the topical treatment of herpes simplex virus assessed using a murine zosteriform infection model.
    Awan AR; Harmenberg J; Flink O; Field HJ
    Antivir Chem Chemother; 1998 Jan; 9(1):19-24. PubMed ID: 9875373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus zosteriform lesions with adoptive transfer of immune cells: a murine model which mimics human recurrent disease.
    Awan AR; Harmenberg J; Kristofferson A; Field HJ
    Antiviral Res; 1998 Apr; 38(1):43-53. PubMed ID: 9614003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
    Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ME-609: a treatment for recurrent herpes simplex virus infections.
    Harmenberg JG; Awan AR; Alenius S; Ståhle L; Erlandsson AC; Lekare G; Flink O; Augustsson E; Larsson T; Wikström AC; Stierna P; Field HJ; Larsson AG; Oberg B
    Antivir Chem Chemother; 2003 Jul; 14(4):205-15. PubMed ID: 14582849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacies of gel formulations containing foscarnet, alone or combined with sodium lauryl sulfate, against establishment and reactivation of latent herpes simplex virus type 1.
    Piret J; Lamontagne J; Désormeaux A; Bergeron MG
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1030-6. PubMed ID: 11257012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis.
    Hull CM; Brunton S
    Postgrad Med; 2010 Sep; 122(5):1-6. PubMed ID: 20873400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of topical foscarnet in a new model of herpes simplex skin infection.
    van Genderen J; Wolthuis OL; Ariens AT; Ericson AC; Datema R
    J Antimicrob Chemother; 1987 Oct; 20(4):547-56. PubMed ID: 2960644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1.
    Biswas S; Jennens L; Field HJ
    Antiviral Res; 2007 Jul; 75(1):30-5. PubMed ID: 17175035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium lauryl sulfate increases the efficacy of a topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice.
    Piret J; Désormeaux A; Cormier H; Lamontagne J; Gourde P; Juhász J; Bergeron MG
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2263-70. PubMed ID: 10952566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
    Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
    Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacies of topical formulations of foscarnet and acyclovir and of 5-percent acyclovir ointment (Zovirax) in a murine model of cutaneous herpes simplex virus type 1 infection.
    Piret J; Désormeaux A; Gourde P; Juhász J; Bergeron MG
    Antimicrob Agents Chemother; 2000 Jan; 44(1):30-8. PubMed ID: 10602719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of mucocutaneous herpes simplex virus infections unresponsive to acyclovir with topical foscarnet cream in AIDS patients: a phase I/II study.
    Javaly K; Wohlfeiler M; Kalayjian R; Klein T; Bryson Y; Grafford K; Martin-Munley S; Hardy WD
    J Acquir Immune Defic Syndr; 1999 Aug; 21(4):301-6. PubMed ID: 10428108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenicity and response to topical antiviral therapy in a murine model of acyclovir-sensitive and acyclovir-resistant herpes simplex viruses isolated from the same patient.
    Lebel A; Boivin G
    J Clin Virol; 2006 Sep; 37(1):34-7. PubMed ID: 16781887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1.
    Lascaux AS; Caumes E; Deback C; Melica G; Challine D; Agut H; Lévy Y
    J Med Virol; 2012 Feb; 84(2):194-7. PubMed ID: 22170537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
    J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
    Verdonck LF; Cornelissen JJ; Smit J; Lepoutre J; de Gast GC; Dekker AW; Rozenberg-Arska M
    Bone Marrow Transplant; 1993 Feb; 11(2):177-9. PubMed ID: 8382096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical treatment with BV-araU of immunosuppressed and immunocompetent shaved mice cutaneously infected with herpes simplex virus type 1.
    Ijichi K; Ashida N; Varia S; Machida H
    Antiviral Res; 1993 May; 21(1):47-57. PubMed ID: 8391248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined activity of meliacin and foscarnet against different strains of herpes simplex virus type 1 using a three-dimensional model].
    Barquero AA; Villamil SM
    Rev Argent Microbiol; 1997; 29(1):32-7. PubMed ID: 9229723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyclovir treatment of skin lesions results in immune deviation in mice infected cutaneously with herpes simplex virus.
    Li Z; Sato H; Fukuda Y; Kurokawa M; Kageyama S; Kawana T; Shiraki K
    Antivir Chem Chemother; 1999 Sep; 10(5):251-7. PubMed ID: 10574180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical foscarnet for aciclovir-resistant mucocutaneous herpes infections in AIDS.
    Smith NA; Wood C; Asboe D; Bingham JS
    AIDS; 1997 Feb; 11(2):254-5. PubMed ID: 9030377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.